Karl Romstedt

541 total citations
34 papers, 462 citations indexed

About

Karl Romstedt is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Karl Romstedt has authored 34 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 12 papers in Molecular Biology and 11 papers in Organic Chemistry. Recurrent topics in Karl Romstedt's work include Inflammatory mediators and NSAID effects (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Karl Romstedt is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Karl Romstedt collaborates with scholars based in United States, Brazil and Thailand. Karl Romstedt's co-authors include Dennis R. Feller, Huzoor‐Akbar, Gamal Shams, Duane D. Miller, Barry W. Festoff, Shamina M. Rangwala, Melissa Sutton, Daniel J. Noonan, Srichan Phornchirasilp and D. R. FELLER and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Gene.

In The Last Decade

Karl Romstedt

34 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Romstedt United States 12 202 120 113 68 57 34 462
Sadahiko Iguchi Japan 12 191 0.9× 150 1.3× 338 3.0× 58 0.9× 24 0.4× 20 707
Mamoru Kanda Japan 13 161 0.8× 46 0.4× 75 0.7× 117 1.7× 27 0.5× 40 418
Beverley Hammond United Kingdom 9 145 0.7× 91 0.8× 66 0.6× 40 0.6× 51 0.9× 11 418
Yoshinobu Arai Japan 12 171 0.8× 151 1.3× 208 1.8× 118 1.7× 34 0.6× 26 572
Katsuichi Shuto Japan 12 246 1.2× 78 0.7× 128 1.1× 119 1.8× 12 0.2× 88 639
Stephen R. Bertenshaw United States 11 126 0.6× 150 1.3× 258 2.3× 57 0.8× 11 0.2× 14 441
Michael J. Randall United States 10 112 0.6× 131 1.1× 100 0.9× 57 0.8× 20 0.4× 13 356
D.L. Venton United States 14 219 1.1× 246 2.0× 109 1.0× 79 1.2× 15 0.3× 38 672
A.V. Wallace United Kingdom 15 326 1.6× 52 0.4× 165 1.5× 198 2.9× 21 0.4× 20 706
Miguel Nomen France 8 185 0.9× 48 0.4× 191 1.7× 222 3.3× 31 0.5× 14 592

Countries citing papers authored by Karl Romstedt

Since Specialization
Citations

This map shows the geographic impact of Karl Romstedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Romstedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Romstedt more than expected).

Fields of papers citing papers by Karl Romstedt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Romstedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Romstedt. The network helps show where Karl Romstedt may publish in the future.

Co-authorship network of co-authors of Karl Romstedt

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Romstedt. A scholar is included among the top collaborators of Karl Romstedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Romstedt. Karl Romstedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Roche, Victoria F., et al.. (2002). Synthesis and In vitro platelet aggregation and TP receptor binding studies on bicyclic 5,8-Ethanooctahydroisoquinolines and 5,8-Ethanotetrahydroisoquinolines. Bioorganic & Medicinal Chemistry. 10(8). 2779–2793. 9 indexed citations
3.
4.
Shams, Gamal, et al.. (1997). β-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs. General Pharmacology The Vascular System. 28(2). 323–330. 7 indexed citations
5.
Romstedt, Karl, Gamal Shams, Vimon Tantishaiyakul, et al.. (1993). Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta. Biochemical Pharmacology. 46(11). 2051–2059. 2 indexed citations
6.
Amemiya, Yoshiya, B. V. Venkataraman, Popat N. Patil, et al.. (1992). Synthesis and .alpha.-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogs. Journal of Medicinal Chemistry. 35(4). 750–755. 19 indexed citations
7.
Romstedt, Karl, Dennis R. Feller, Fu‐Lian Hsu, et al.. (1992). Resolution and adrenergic activities of the optical isomers of 4‐[1‐(1‐Naphthyl)ethyl]‐1H‐imidazole. Chirality. 4(7). 432–438. 4 indexed citations
8.
Romstedt, Karl, et al.. (1991). Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo. Chirality. 3(2). 112–117. 5 indexed citations
9.
Venkataraman, B. V., Gamal Shams, Atsushi Hamada, et al.. (1991). Structure-activity studies of new imidazolines on adrenoceptors of rat aorta and human platelets. Naunyn-Schmiedeberg s Archives of Pharmacology. 344(4). 454–63. 4 indexed citations
10.
Shams, Gamal, Karl Romstedt, Adeboye Adejare, et al.. (1991). Pharmacological properties of novel bicyclic isoquinoline analogs in isolated guinea pig atria, trachea and in human platelets: Relationship to trimetoquinol. General Pharmacology The Vascular System. 22(6). 1155–1163. 2 indexed citations
11.
Miller, Duane D., Akihiko Hamada, Adeboye Adejare, et al.. (1990). Synthesis and .alpha.2-adrenoceptor effects of substituted catecholimidazoline and catecholimidazole analogs in human platelets. Journal of Medicinal Chemistry. 33(4). 1138–1144. 25 indexed citations
12.
Shams, Gamal, et al.. (1990). Pharmacological evaluation of the β-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues. European Journal of Pharmacology. 184(1). 21–31. 6 indexed citations
13.
FELLER, D. R., B. V. Venkataraman, Karl Romstedt, et al.. (1990). Alpha adrenergic activities of aromatic ring iodinated analogues of catecholimidazoline in blood vessels and platelets. European Journal of Pharmacology. 183(3). 993–993. 1 indexed citations
14.
Hink, W.F., et al.. (1989). Inhibition of human platelet aggregation and secretion by ant venom and a compound isolated from venom. Inflammation. 13(2). 175–184. 10 indexed citations
15.
Wallace, David K., et al.. (1988). Human platelet activation by bacterial phospholipase C: Mechanism of inhibition by flurazepam. Thrombosis Research. 49(2). 225–239. 6 indexed citations
16.
Romstedt, Karl, et al.. (1988). Synthesis and thromboxane A2 antagonist activity of N-benzyltrimetoquinol analogs. Journal of Medicinal Chemistry. 31(8). 1506–1512. 7 indexed citations
17.
Witiak, Donald T., Sung K. Kim, Karl Romstedt, Howard Newman, & Dennis R. Feller. (1986). Comparative antiaggregatory activity in human platelets of a benzopyranone aci-reductone, clofibric acid, and a 2,3-dihydrobenzofuran analog. Journal of Medicinal Chemistry. 29(11). 2170–2174. 3 indexed citations
18.
Romstedt, Karl, et al.. (1985). Beclobrinic acid— A new hypolipidemic agent— Inhibits human platelet activation by blocking prostaglandin synthesis. Life Sciences. 37(1). 63–70. 2 indexed citations
19.
Huzoor‐Akbar & Karl Romstedt. (1984). 3 Deazaadenosine and L-homocysteine inhibit human platelet activation induced by arachidonic acid, U46619 and phospholipase C. Thrombosis Research. 36(4). 369–376. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sadahiko Iguchi Breakdown of academic impact, for papers by Mamoru Kanda Breakdown of academic impact, for papers by Beverley Hammond Breakdown of academic impact, for papers by Yoshinobu Arai Breakdown of academic impact, for papers by Katsuichi Shuto Breakdown of academic impact, for papers by Stephen R. Bertenshaw Breakdown of academic impact, for papers by Michael J. Randall Breakdown of academic impact, for papers by D.L. Venton Breakdown of academic impact, for papers by A.V. Wallace Breakdown of academic impact, for papers by Miguel Nomen
Rankless by CCL
2026